Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.

Csernansky JG, Mahmoud R, Brenner R; Risperidone-USA-79 Study Group.

N Engl J Med. 2002 Jan 3;346(1):16-22. Erratum in: N Engl J Med 2002 May 2;346(18):1424.

2.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
3.

The routine use of atypical antipsychotic agents: maintenance treatment.

Kinon BJ.

J Clin Psychiatry. 1998;59 Suppl 19:18-22. Review.

4.

Angioneurotic edema with risperidone: a case report and review of literature.

Soumya RN, Grover S, Dutt A, Gaur N.

Gen Hosp Psychiatry. 2010 Nov-Dec;32(6):646.e1-3. doi: 10.1016/j.genhosppsych.2010.03.005. Epub 2010 Apr 2. Review.

PMID:
21112458
5.

Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.

Awouters FH, Lewi PJ.

Arzneimittelforschung. 2007;57(10):625-32. Review.

PMID:
18074755
6.

Pharmacological prevention of relapse.

Lader M.

Kaohsiung J Med Sci. 1998 Jul;14(7):448-57. Review.

PMID:
9739577
7.

The nature of relapse in schizophrenia.

Emsley R, Chiliza B, Asmal L, Harvey BH.

BMC Psychiatry. 2013 Feb 8;13:50. doi: 10.1186/1471-244X-13-50. Review.

8.

[Pregnancy and fertility in schizophrenia].

Grootens KP.

Ned Tijdschr Geneeskd. 2014;158:A7274. Review. Dutch.

PMID:
24754930
9.

Clinical factors related to schizophrenia relapse.

Porcelli S, Bianchini O, De Girolamo G, Aguglia E, Crea L, Serretti A.

Int J Psychiatry Clin Pract. 2016;20(2):54-69. doi: 10.3109/13651501.2016.1149195. Epub 2016 Apr 7. Review.

PMID:
27052109

Supplemental Content

Support Center